Introduction: The liver is the main site of organ for coagulation system. Liver plays a predominant role in regulation of hemostasis. Hepatic disorders are widely prevalent in tropical countries are responsible for morbidity and mortality. Aims and Objective: The diagnosis of liver diseases by assisting in differential diagnosis with various coagulation tests. In assessment of prognosis of patients of various liver disease.
Introduction
Liver is an important organ of the body having functions of synthesis of plasma proteins and a range of blood clotting factors being produced, some of them exclusively in the organ. All of them are deranged in various liver disorders. 1 Liver plays a predominant role in the regulation of haemostasis. Both cellular and plasmatic coagulation are defective, representing a hallmark of advanced liver disease. 2 Laboratory tests, coagulation tests and liver function tests are useful in the evaluation, management and assessment of prognosis. They provide a sensitive, noninvasive method of screening for the presence of liver dysfunction. 3 Along with function of synthesis of protease inhibitors, liver also clears activated clotting factors from blood. Intravascular coagulation has been reported as frequently occurring in patients with acute liver failure. The resultant consumption coagulopathy complicates a pre-existing coagulation defect due to further depletion of fibrinogen, factor V and factor IX and X. 5 Considering above mentioned factors and importance of coagulation tests which is helpful in evaluation of various hepatic disorders, the present study is undertaken.
Aims and Objectives 1. The diagnosis of liver diseases by assisting in differential diagnosis with various coagulation tests. 2. In assessment of prognosis of patients of various liver disease. 3. In the prediction of response to treatment for liver disease.
Materials and Methods
The present study was conducted on 100 patients having liver disease attending Medicine and Paediatric clinics at tertiary care hospital. They were divided into following three groups: 40 cases of cirrhosis (Bleeders, Non bleeders), 40 cases of viral hepatitis and 20 cases of Obstructive jaundice.
Blood samples from the patients were collected and following coagulation tests were performed. Discussion One hundred patients of various liver diseases with various clinical manifestations studied for coagulation abnormalities by doing coagulation tests like bleeding time, platelet count, fibrinogen estimation and prothrombin time and activated partial prothrombin time. With this other normal 25 persons also studied for control.
The results obtained are tabulated and compared with those of previously published studies in various years and similar work of well-known workers in this field. Table 2 shows, in cirrhosis, the bleeding time in both bleeders and non bleeders is within normal range, as shown by present study and other worker's study. But the mean value for bleeders is quite higher than non bleeders as shown by Poonam Rastogi 9 et al in 18 cases and present study in 20 cases. So this values are quite comparable in present study with study of Poonam Rastogi et al. 9 In viral hepatitis, 40 cases show range of 140+ 25 sec which is normal range and similar observations was made by Ratnoff et al 7 and Donaldson et al and Singh et al. 8 In obstructive jaundice, bleeding time is comparable with those of other studies. Table 3 shows in cirrhosis, the Clotting time in both bleeders and non bleeders is within normal range, as shown by present study and other worker's study. But the mean value for bleeders is quite higher than non bleeders as shown by Poonam Rastogi et al 9 in 18 cases and present study in 20 cases. So this values are quite comparable in present study with study of Poonam Rastogi et al. 9 Similar observations are made by other Authors. Thus it is clear that Clotting time is not much significant test for cirrotic patients.
In viral hepatitis, present study show range for clotting time 285+55 sec. Similar observations was made by other studies and present study is comparable with other studies and indicate that clotting time is not much significant test for hepatitis. Same observations were made for obstructive jaundice and also comparable with other studies. Table 4 shows in cirrhosis of liver, in present study 95% elevation of PT is seen in bleeder in range of 32.3+ 14.3. This shows similar results in all the workers, which is comparable with present study showing high prothrombin time. In non bleeders, results are variable due to 1. Variation in patients population and can be attributed to our exclusion of minor degree of bleeding.
In Viral hepatitis, present study show elevation of PT which is comparable with study of S. Gurdoy et al. 12 In Obstructuve jaundice, all 20 cases(100%) show elevation in our study. Overall results and present study of PT are quite comparable with other worker's results in all liver diseases. Table 5 shows in cirrhosis, in present study shows elevation in aPTT in 16 cases (80%) in bleeders in range of 44.6+ 4.6 and 20 cases (15%) in non bleeders with range of 35.8+ 5.8 which is comparable with other study.
In viral hepatitis 22.5% cases show elevation in aPTT by present study. Similar observations were made by above mentioned authors in their studies.
In obstructive jaundice, 55% cases show prolongation of aPTT by present study. No other worker has done similar study. As per above results observed by present study showing elevation value of APTT which is quite comparable with the other results. Table 6 shows study of fibrinogen in liver disease by comparison of other workers with present study.in cirrhosis, observations show hypofibrigenemia in Norber's study and present study which is quite comparable. The minor variation of results may be due to different number of cases studied and population difference of patients studied.
In viral hepatitis observations show hypofibrigenemia which is comparable with other studies.
In obstructive jaundice. Present study 20 cases studied with results in range of 230+ 30 mg% is seen which is in normal range. No other workers have done similar study in obstructive jaundice Hypofibrigenemia in bleeders noted by all workers are almost similar with present study. Same observations are seen in non bleeders cases. In viral hepatitis and obstructive jaundice mild degree of hypofibrigenemia is seen i.e. 2.5% cases it suggests fibrinogen has not much significant value in viral hepatitis and obstructive jaundice.
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